Our Sponsors
Website http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=701844?channel=ourglocal |
Edit Freely
Category Laboratory Compliance; pharmaceutical manufacturing; pharmaceutical procedures; QC testing; GLP; GMP
Deadline: February 10, 2012 | Date: February 10, 2012
Venue/Country: Palo Alto, U.S.A
Updated: 2012-01-24 14:10:56 (GMT+9)
In this 2-hr webinar you will learn how to differentiate and draw boundaries for GMP and GLP practices if done in same laboratory and how to transition a procedure in development to one used routinely.
Why Should You Attend:If a laboratory is dedicated either to GMP testing and validation activities or to method and procedure development and validation, then the laboratory is responsible for following the appropriate CFRs. GMP guidance’s for the pharmaceutical industry are included in 21 CFR, and for GLP guidance’s can be found in 58 CFR. However, if both types of work are being done in the same laboratory and even by the same analysts, it is critical to define boundaries. This involves not only the analysts and the laboratory management but extends to reviewers of critical documents and client education regarding the practices and policies.
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.